New pill aims to stop chronic hives fast when antihistamines fail
Symptom relief
Not yet recruiting
This early-phase trial tests a new drug called TLL-018 in 36 adults with moderate-to-severe chronic spontaneous urticaria (hives) that standard antihistamines can't control. The goal is to see how quickly TLL-018 reduces itching and hives after the first dose. Participants will r…
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC